Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  van de Weijer, Tineke ^a   Sparks, Lauren Marie ^a   Phielix, Esther ^a   Meex, Ruth Carla ^a   van Herpen, Noud Antonius ^a   Hesselink, Matthijs Karel C ^a   Schrauwen, Patrick ^a   Schrauwen Hinderling, Vera Bettina ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC FLEXIBILITY; METABOLIC PARAMETERS; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; OBESITY;

EID: 84873912710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051648     Document Type: Article

References (39)

1. Kelley DE, Mandarino LJ, (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-683.
2. Kelley DE, Goodpaster B, Wing RR, Simoneau JA, (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277: E1130-1141.
3. Corpeleijn E, Saris WH, Blaak EE, (2009) Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev 10: 178-193.
4. Galgani JE, Heilbronn LK, Azuma K, Kelley DE, Albu JB, et al. (2008) Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 57: 841-845.
5. Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, et al. (1988) Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 585-591.
6. Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP, (1988) Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp. Diabete Metab 14: 443-451.
7. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ, (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92: 91-98.
8. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, et al. (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600-1606.
9. Jacob S, Machann J, Rett K, Brechtel K, Volk A, et al. (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119.
10. Eckel RH, Grundy SM, Zimmet PZ, (2005) The metabolic syndrome. Lancet 365: 1415-1428.
11. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274.
12. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, et al. (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259.
13. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, et al. (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50: 113-120.
14. Schrauwen-Hinderling VB, Mensink M, Hesselink MK, Sels JP, Kooi ME, et al. (2008) The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function. J Clin Endocrinol Metab 93: 2917-2921.
15. van Herpen NA, Schrauwen-Hinderling VB, Schaart G, Mensink RP, Schrauwen P (2011) Three Weeks on a High-Fat Diet Increases Intrahepatic Lipid Accumulation and Decreases Metabolic Flexibility in Healthy Overweight Men. J Clin Endocrinol Metab.
16. Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, Schaart G, Mensink M, et al. (2010) Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59: 572-579.
17. Phielix E, Schrauwen-Hinderling VB, Mensink M, Lenaers E, Meex R, et al. (2008) Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57: 2943-2949.
18. Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G, (1985) Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 6: 197-201.
19. Siri WE, (1956) The gross composition of the body. Adv Biol Med Phys 4: 239-280.
20. DeFronzo RA, Tobin JD, Andres R, (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223.
21. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH, (2001) Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50: 2548-2554.
22. Bergstrom J, Hermansen L, Hultman E, Saltin B, (1967) Diet, muscle glycogen and physical performance. Acta Physiol Scand 71: 140-150.
23. Koopman R, Schaart G, Hesselink MK, (2001) Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116: 63-68.
24. Frayn KN, (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634.
25. Steele R, (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82: 420-430.
26. Boden G, Chen X, Ruiz J, White JV, Rossetti L, (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438-2446.
27. McGarry JD, (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766-770.
28. Randle PJ, Garland PB, Hales CN, Newsholme EA, (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
29. DeFronzo RA (2004) Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl: 9-21.
30. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, et al. (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461-2474.
31. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK, (2010) Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 1801: 266-271.
32. Rabol R, Svendsen PF, Skovbro M, Boushel R, Haugaard SB, et al. (2009) Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss. Metabolism 58: 1145-1152.
33. Snel M, Gastaldelli A, Ouwens DM, Hesselink MK, Schaart G, et al. (2012) Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients. J Clin Endocrinol Metab 97: 2512-2520.
34. Galgani JE, Johannsen NM, Bajpeyi S, Costford SR, Zhang Z, et al. (2012) Role of skeletal muscle mitochondrial density on exercise-stimulated lipid oxidation. Obesity (Silver Spring) 20: 1387-1393.
35. Rabol R, Boushel R, Dela F, (2006) Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 31: 675-683.
36. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, et al. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-796.
37. Han DH, Nolte LA, Ju JS, Coleman T, Holloszy JO, et al. (2004) UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. Am J Physiol Endocrinol Metab 286: E347-353.
38. Hoeks J, Hesselink MK, Russell AP, Mensink M, Saris WH, et al. (2006) Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49: 2419-2426.
39. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, et al. (2007) Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592-1599.